HeimJNJ • NYSE
add
Johnson & Johnson
Við síðustu lokun
142,27 $
Dagbil
140,68 $ - 143,67 $
Árabil
140,68 $ - 168,85 $
Markaðsvirði
342,03 ma. USD
Meðalmagn
8,17 m.
V/H-hlutf.
23,48
A/V-hlutfall
3,49%
Aðalkauphöll
NYSE
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 22,47 ma. | 5,25% |
Rekstrarkostnaður | 10,20 ma. | 18,80% |
Nettótekjur | 2,69 ma. | -89,65% |
Hagnaðarhlutfall | 11,99 | -90,16% |
Hagnaður á hvern hlut | 2,42 | -9,02% |
EBITDA | 7,36 ma. | -10,41% |
Virkt skatthlutfall | 19,29% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 20,30 ma. | -13,67% |
Heildareignir | 178,29 ma. | 7,36% |
Heildarskuldir | 108,13 ma. | 14,02% |
Eigið fé alls | 70,16 ma. | — |
Útistandandi hlutabréf | 2,41 ma. | — |
Eiginfjárgengi | 4,88 | — |
Arðsemi eigna | 7,66% | — |
Ávöxtun eigin fjár | 12,58% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 2,69 ma. | -89,65% |
Handbært fé frá rekstri | 7,99 ma. | — |
Reiðufé frá fjárfestingum | -3,13 ma. | — |
Reiðufé frá fjármögnun | -9,88 ma. | — |
Breyting á handbæru fé | -4,90 ma. | — |
Frjálst peningaflæði | 5,50 ma. | — |
Um
Johnson & Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.
Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. In 2023, the company split-off its consumer healthcare business sector into a new publicly traded company, Kenvue. The company is exclusively focused on developing and producing pharmaceutical prescription drugs and medical device technologies.
Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA. Wikipedia
Framkvæmdastjóri
Stofnsett
jan. 1886
Höfuðstöðvar
Vefsvæði
Starfsfólk
131.900
